The concern regarding an early increase in risk was most prominently highlighted by the SUSTAIN-6 trial, which found that patients undergoing semaglutide treatment exhibited an elevated risk of diabetic retinopathy complications [82]
However, these medications may not be suitable if you: Have a history of thyroid cancer or pancreatitis Are currently pregnant or breastfeeding Have severe digestive issues like gastroparesis GLP-1s and Metabolism: Why Theyre Different from Other Weight Loss Drugs and Lower Blood Sugar Levels Many weight loss drugs work by increasing metabolism artificially, leading to potential issues like heart palpitations, anxiety, or dependency
Their tagline is Made for women, by women, and they also have clinicians on-hand to craft personalized care plans for their customers
Additionally, by stimulating insulin secretion in a glucose-dependent manner, semaglutide helps regulate blood glucose levels, which can minimize insulin-driven fat storage
The full program rollout is ongoing
Support the Gut Microbiome GLP-1 drugs change what reaches your lower intestine, and that shifts which bacteria thrive down there
